- Home
- CNC vs ZBH Comparison
CNC vs ZBH Comparison
Compare CNC & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNC | ZBH |
|---|---|---|
| Founded | 1984 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.5B | 19.5B |
| IPO Year | 2001 | 2001 |
Fundamental Metrics
Financial Performance| Metric | CNC | ZBH |
|---|---|---|
| Price | $43.41 | $93.29 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 17 | 19 |
| Target Price | $41.69 | ★ $105.17 |
| AVG Volume (30 Days) | ★ 4.3M | 2.2M |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 1.02% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.55 |
| Revenue | ★ $194,777,000,000.00 | $8,231,500,000.00 |
| Revenue This Year | $8.11 | $4.93 |
| Revenue Next Year | $1.51 | $3.72 |
| P/E Ratio | ★ N/A | $26.48 |
| Revenue Growth | ★ 19.44 | 7.20 |
| 52 Week Low | $25.08 | $84.59 |
| 52 Week High | $66.03 | $114.44 |
Technical Indicators
Market Signals| Indicator | CNC | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 52.14 | 44.61 |
| Support Level | $37.25 | $89.38 |
| Resistance Level | $47.68 | $95.33 |
| Average True Range (ATR) | 1.47 | 2.30 |
| MACD | 0.13 | -0.86 |
| Stochastic Oscillator | 56.88 | 22.74 |
Price Performance
Historical ComparisonAbout CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.